ReviewPharmaceutical research2018
Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.
Willem Johan van den Brink et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewPharmaceutical research2018
Willem Johan van den Brink et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.